To investigate the role of PHD2 in MLL-AF9-driven AML in vivo, we transplanted iMLL-AF9;Control and iMLL-AF9;shPhd2 LSK cells into DOX-treated recipient mice (Fig. 1i). The gene discussed is EGLN1; the disease is acute myeloid leukemia.